听力与言语-语言病理学

行为科学

医学伦理学

你正在浏览CANCER期刊下所有文献
  • The future of cancer screening after COVID-19 may be at home.

    abstract:LAY SUMMARY:During the coronavirus disease 2019 (COVID-19) pandemic, cancer screening decreased precipitously; home screening for colorectal cancer diminished less than that for colonoscopy and breast and cervical cancer screening. The authors have highlighted approaches for home cancer screening in addition to telemed...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33274

    authors: Gorin SNS,Jimbo M,Heizelman R,Harmes KM,Harper DM

    更新日期:2021-02-15 00:00:00

  • Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States.

    abstract:BACKGROUND:The association of community factors and outcomes after hematopoietic cell transplantation (HCT) has not been comprehensively described. Using the County Health Rankings and Roadmaps (CHRR) and the Center for International Blood and Marrow Transplant Research (CIBMTR), this study evaluated the impact of comm...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33232

    authors: Hong S,Brazauskas R,Hebert KM,Ganguly S,Abdel-Azim H,Diaz MA,Beattie S,Ciurea SO,Szwajcer D,Badawy SM,Gratwohl AA,LeMaistre C,Aljurf MDSM,Olsson RF,Bhatt NS,Farhadfar N,Yared JA,Yoshimi A,Seo S,Gergis U,Beitinjane

    更新日期:2021-02-15 00:00:00

  • Social needs and health-related quality of life among African American cancer survivors: Results from the Detroit Research on Cancer Survivors study.

    abstract:BACKGROUND:Social needs may affect cancer survivors' health-related quality of life (HRQOL) above and beyond sociodemographic and cancer-related factors. The purpose of this study was to estimate associations between social needs and HRQOL. METHODS:Results included data from 1754 participants in the Detroit Research o...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33286

    authors: Hastert TA,McDougall JA,Strayhorn SM,Nair M,Beebe-Dimmer JL,Schwartz AG

    更新日期:2021-02-01 00:00:00

  • Dose-escalation study of vemurafenib with sorafenib or crizotinib in patients with BRAF-mutated advanced cancers.

    abstract:BACKGROUND:BRAF inhibitors are effective in melanoma and other cancers with BRAF mutations; however, patients ultimately develop therapeutic resistance through the activation of alternative signaling pathways such as RAF/RAS or MET. The authors hypothesized that combining the BRAF inhibitor vemurafenib with either the ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33242

    authors: Janku F,Sakamuri D,Kato S,Huang HJ,Call SG,Naing A,Holley VR,Patel SP,Amaria RN,Falchook GS,Piha-Paul SA,Zinner RG,Tsimberidou AM,Hong DS,Meric-Bernstam F

    更新日期:2021-02-01 00:00:00

  • Adherence to endocrine therapy including ovarian suppression: A large observational cohort study of US women with early breast cancer.

    abstract:BACKGROUND:Recent clinical trials support adding ovarian suppression (OS) to oral endocrine therapy (ET) for premenopausal women with early breast cancer. The adoption of OS among real-world populations and the impact of OS on ET adherence have not been evaluated. METHODS:This study examined a retrospective, observati...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33367

    authors: Reeder-Hayes KE,Mayer SE,Lund JL

    更新日期:2021-01-28 00:00:00

  • Nonaspirin nonsteroidal anti-inflammatory drugs and gastric cancer risk after Helicobacter pylori eradication: A territory-wide study.

    abstract:BACKGROUND:Despite Helicobacter pylori (HP) eradication, individuals can still develop gastric cancer (GC). Prior studies have demonstrated that nonaspirin nonsteroidal anti-inflammatory drugs (NA-NSAIDs) reduce the risk of GC, but this may be caused by immortal time bias and failure to adjust for HP status. The object...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33412

    authors: Li B,Cheung KS,Wong IY,Leung WK,Law S

    更新日期:2021-01-20 00:00:00

  • Stage and mortality of low-income patients with cancer: Evidence from SEER-Medicaid.

    abstract:BACKGROUND:A national data source for identifying patients with cancer enrolled in Medicaid is needed to evaluate cancer care for low-income, publicly insured patients. In this study, a population-based data set of patients diagnosed with cancer and enrolled in Medicaid was created and evaluated. The objective was to c...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33207

    authors: Bradley CJ,Stevens JL,Enewold L,Warren JL

    更新日期:2021-01-15 00:00:00

  • Physical fitness and modifiable cardiovascular disease risk factors in survivors of childhood cancer: A report from the SURfit study.

    abstract:BACKGROUND:Childhood cancer survivors are at risk for cardiovascular disease (CVD) because of intensive cancer therapies often accompanied by an unhealthy lifestyle. This study was aimed at 1) describing modifiable CVD risk factors in survivors and 2) investigating the association between different aspects of physical ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33351

    authors: Schindera C,Zürcher SJ,Jung R,Boehringer S,Balder JW,Rueegg CS,Kriemler S,von der Weid NX

    更新日期:2021-01-06 00:00:00

  • Validation of the caregiver Pediatric Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events measure.

    abstract:BACKGROUND:Despite improvements in survival rates, cancer treatments have significant side effects that affect the quality of life of children and their families. When an ill child cannot self-report symptoms (eg, he or she is too ill), caregiver (parent) reporting becomes critical. This study evaluates the validity an...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33389

    authors: Reeve BB,McFatrich M,Lin L,Lucas NR,Mack JW,Jacobs SS,Withycombe JS,Baker JN,Freyer DR,Hinds PS

    更新日期:2020-12-17 00:00:00

  • Response rate and local recurrence after concurrent immune checkpoint therapy and radiotherapy for non-small cell lung cancer and melanoma brain metastases.

    abstract:BACKGROUND:Prior literature has suggested synergy between immune checkpoint therapy (ICT) and radiotherapy (RT) for the treatment of brain metastases (BrM), but to the authors' knowledge the optimal timing of therapy to maximize this synergy is unclear. METHODS:A total of 199 patients with melanoma and non-small cell ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33196

    authors: Qian JM,Martin AM,Martin K,Hammoudeh L,Catalano PJ,Hodi FS,Cagney DN,Haas-Kogan DA,Schoenfeld JD,Aizer AA

    更新日期:2020-12-15 00:00:00

  • SARC025 arms 1 and 2: A phase 1 study of the poly(ADP-ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma.

    abstract:BACKGROUND:In preclinical Ewing sarcoma (ES) models, poly(adenosine diphosphate ribose) polymerase (PARP) inhibitors were identified as a potential therapeutic strategy with synergy in combination with cytotoxic agents. This study evaluated the safety and dosing of the PARP1/2 inhibitor niraparib (NIR) with temozolomid...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33349

    authors: Chugh R,Ballman KV,Helman LJ,Patel S,Whelan JS,Widemann B,Lu Y,Hawkins DS,Mascarenhas L,Glod JW,Ji J,Zhang Y,Reinke D,Strauss SJ

    更新日期:2020-12-08 00:00:00

  • Role of cancer survivor health and health service use in spouses' use of mental health-related care.

    abstract:BACKGROUND:Spouses of cancer survivors are at an increased risk of poor mental health outcomes but are known to underuse supportive services. The objective of the current study was to determine how the health and health care use of cancer survivors were associated with depression and anxiety-related health care use in ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33345

    authors: Litzelman K,Choi H,Maher ME,Harnish A

    更新日期:2020-12-08 00:00:00

  • Clinical behavior of recurrent hormone receptor-positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1-98 clinical trial.

    abstract:BACKGROUND:Endocrine therapy resistance is a major cause of distant recurrence (DR) in hormone receptor-positive breast cancer. This study evaluated differences in survival after DR in patients treated with different adjuvant endocrine therapy regimens in the Breast International Group (BIG) 1-98 trial. METHODS:BIG 1-...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33318

    authors: Leone JP,Cole BF,Regan MM,Thürlimann B,Coates AS,Rabaglio M,Giobbie-Hurder A,Gelber RD,Ejlertsen B,Harvey VJ,Neven P,Láng I,Bonnefoi H,Wardley A,Goldhirsch A,Di Leo A,Colleoni M,Vaz-Luis I,Lin NU

    更新日期:2020-12-08 00:00:00

  • Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma.

    abstract:BACKGROUND:Upfront autologous hematopoietic stem cell transplantation (AHCT) remains an important therapy in the management of patients with multiple myeloma (MM), a disease of older adults. METHODS:The authors investigated the outcomes of AHCT in patients with MM who were aged ≥70 years. The Center for International ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33171

    authors: Munshi PN,Vesole D,Jurczyszyn A,Zaucha JM,St Martin A,Davila O,Agrawal V,Badawy SM,Battiwalla M,Chhabra S,Copelan E,Kharfan-Dabaja MA,Farhadfar N,Ganguly S,Hashmi S,Krem MM,Lazarus HM,Malek E,Meehan K,Murthy HS,Ni

    更新日期:2020-12-01 00:00:00

  • A framework for cancer health economics research.

    abstract:LAY SUMMARY:Cancer has substantial economic impacts for patients, their families and/or caregivers, employers, and the health care system. However, there is only limited understanding of how economic issues can affect access to cancer care services and the receipt of high-quality cancer care. Health economics research ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33343

    authors: Halpern MT,Shih YT,Yabroff KR,Ekwueme DU,Bradley CJ,Davidoff AJ,Sabik LM,Lipscomb J

    更新日期:2020-11-25 00:00:00

  • The METeoric rise of MET in lung cancer.

    abstract::Over the years, there has been a continuous increase in clinically relevant driver mutations in patients with non-small cell lung cancer (NSCLC). Among these, dysregulated activation of the MET tyrosine kinase receptor has gained importance due to the recent development of quite effective treatments. MET dysregulation...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.33159

    authors: Friedlaender A,Drilon A,Banna GL,Peters S,Addeo A

    更新日期:2020-11-15 00:00:00

  • A multi-institutional phase 2 trial of stereotactic body radiotherapy in the treatment of bone metastases in pediatric and young adult patients with sarcoma.

    abstract:BACKGROUND:Metastasectomy is standard of care for pediatric patients with metastatic sarcoma with limited disease. For patients with unresectable disease, stereotactic body radiotherapy (SBRT) may serve as an alternative. Herein, the authors report the results of a prospective, multi-institutional phase 2 trial of SBRT...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33306

    authors: Elledge CR,Krasin MJ,Ladra MM,Alcorn SR,Han P,Gibbs IC,Hiniker SM,Laack NN,Terezakis SA

    更新日期:2020-11-10 00:00:00

  • Positive impact of the Patient Protection and Affordable Care Act Medicaid expansion on Louisiana women with breast cancer.

    abstract:BACKGROUND:Louisiana is one of the few Southern states that enacted the Medicaid expansion of the Patient Protection and Affordable Care Act (ACA). To the authors' knowledge, the issue of how this has affected the breast cancer landscape in Louisiana is unknown. The authors have postulated that ACA expansion had a posi...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33265

    authors: Chu QD,Li T,Hsieh MC,Yi Y,Gibbs JF,Lyons JM 3rd,Wu XC

    更新日期:2020-11-03 00:00:00

  • Low participation rates and disparities in participation in interventional clinical trials for myelodysplastic syndromes.

    abstract:BACKGROUND:The development of novel therapies for the myelodysplastic syndromes (MDS) is hampered by inadequate trial recruitment. Factors contributing to low trial accrual are incompletely understood. METHODS:This study analyzed a pooled patient database from institutions of the US MDS Clinical Research Consortium to...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33105

    authors: Brierley CK,Zabor EC,Komrokji RS,DeZern AE,Roboz GJ,Brunner AM,Stone RM,Sekeres MA,Steensma DP

    更新日期:2020-11-01 00:00:00

  • Chemotherapy-induced peripheral neuropathy: Identifying the research gaps and associated changes to clinical trial design.

    abstract:BACKGROUND:To the authors' knowledge, the empiric identification of agents and interventions to mitigate chemotherapy-induced peripheral neuropathy (CIPN) has resulted in only 1 agent that modestly mitigates it and no agents or interventions that prevent its development. This speaks to the need for a mechanistic unders...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33108

    authors: St Germain DC,O'Mara AM,Robinson JL,Torres AD,Minasian LM

    更新日期:2020-10-15 00:00:00

  • Pediatric cancer mortality and survival in the United States, 2001-2016.

    abstract:BACKGROUND:Although pediatric cancer mortality and survival have improved in the United States over the past 40 years, differences exist by age, race/ethnicity, cancer site, and economic status. To assess progress, this study examined recent mortality and survival data for individuals younger than 20 years. METHODS:Ag...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33080

    authors: Siegel DA,Richardson LC,Henley SJ,Wilson RJ,Dowling NF,Weir HK,Tai EW,Buchanan Lunsford N

    更新日期:2020-10-01 00:00:00

  • Overcoming sociodemographic factors in the care of patients with testicular cancer at a safety net hospital.

    abstract:BACKGROUND:The objective of this study was to determine whether standardized treatment of germ cell tumors (GCTs) could overcome sociodemographic factors limiting patient care. METHODS:The records of all patients undergoing primary treatment for GCTs at both a public safety net hospital and an academic tertiary care c...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33076

    authors: Chertack N,Ghandour RA,Singla N,Freifeld Y,Hutchinson RC,Courtney K,Bowman IA,Arafat W,Meng X,Moore JA,Aydin AM,Sagalowsky AI,Margulis V,Lotan Y,Woldu SL,Bagrodia A

    更新日期:2020-10-01 00:00:00

  • The effect of Medicaid expansion among adults from low-income communities on stage at diagnosis in those with screening-amenable cancers.

    abstract:BACKGROUND:Several states have opted to expand Medicaid under the Patient Protection and Affordable Care Act (ACA), which offers insurance coverage to low-income individuals up to 138% of the federal poverty level. This expansion of Medicaid to a medically vulnerable population potentially can reduce cancer outcome dis...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.32895

    authors: Kim U,Koroukian S,Statler A,Rose J

    更新日期:2020-09-15 00:00:00

  • Impact of the coronavirus disease 2019 (COVID-19) pandemic on pediatric oncology care in the Middle East, North Africa, and West Asia region: A report from the Pediatric Oncology East and Mediterranean (POEM) group.

    abstract:BACKGROUND:Childhood cancer is a highly curable disease when timely diagnosis and appropriate therapy are provided. A negative impact of the coronavirus disease 2019 (COVID-19) pandemic on access to care for children with cancer is likely but has not been evaluated. METHODS:A 34-item survey focusing on barriers to ped...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33075

    authors: Saab R,Obeid A,Gachi F,Boudiaf H,Sargsyan L,Al-Saad K,Javakhadze T,Mehrvar A,Abbas SS,Abed Al-Agele YS,Al-Haddad S,Al Ani MH,Al-Sweedan S,Al Kofide A,Jastaniah W,Khalifa N,Bechara E,Baassiri M,Noun P,El-Houdzi J,K

    更新日期:2020-09-15 00:00:00

  • Global, regional, and national burden of lung cancer and its attributable risk factors, 1990 to 2017.

    abstract:BACKGROUND:China's lung cancer (LC) burden plays a pivotal role in the global cancer epidemic. Comparing LC burden and population attributable fractions (PAFs) of risk factors between China and other countries/regions is essential to inform effective intervention. The Global Burden of Disease (GBD) study provides a uni...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33078

    authors: Wang N,Mengersen K,Tong S,Kimlin M,Zhou M,Hu W

    更新日期:2020-09-15 00:00:00

  • Survival outcome of adjuvant chemotherapy in deficient mismatch repair stage III colon cancer.

    abstract:BACKGROUND:The prognostic impact of DNA mismatch repair (MMR) status remains controversial in patients with stage III colon cancer who are treated with adjuvant chemotherapy (AC). The aim of this study was to evaluate the survival outcome of AC in deficient mismatch repair (dMMR)/microsatellite instable (MSI) stage III...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33049

    authors: Shaib WL,Zakka KM,Jiang R,Yan M,Alese OB,Akce M,Wu C,Behera M,El-Rayes BF

    更新日期:2020-09-15 00:00:00

  • Chinese expert consensus on the clinical diagnosis and treatment of advanced breast cancer (2018).

    abstract::Breast cancer is the most common malignant tumor among women in the world. In 2005, there were approximately 272,000 new cases diagnosed and more than 70,000 deaths from breast cancer in China. Of the patients who are newly diagnosed with breast cancer each year, approximately 3% to 10% have distant metastases at the ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.32832

    authors: Xu B,Hu X,Feng J,Geng C,Jin F,Li H,Li M,Li Q,Liao N,Liu D,Liu J,Liu Q,Lu J,Liu Z,Ma F,Ouyang Q,Pan Y,Shen K,Sun T,Teng Y,Tong Z,Wang B,Wang H,Wang S,Wang S,Wang T,Wang X,Wang X,Wang Y,Wang Z,Wu

    更新日期:2020-08-15 00:00:00

  • Patterns and predictors of cancer-related fatigue in ovarian and endometrial cancers: 1-year longitudinal study.

    abstract:BACKGROUND:Fatigue is a common and distressing symptom for patients with gynecologic cancers. Few studies have empirically examined whether it spontaneously resolves. This study was aimed at identifying longitudinal patterns of fatigue and predictors of clinically significant fatigue 1 year after treatment completion. ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.32927

    authors: Poort H,de Rooij BH,Uno H,Weng S,Ezendam NPM,van de Poll-Franse L,Wright AA

    更新日期:2020-08-01 00:00:00

  • Importance of quality-of-life priorities and preferences surrounding treatment decision making in patients with cancer and oncology clinicians.

    abstract:BACKGROUND:Shared decision-making (SDM) occurs when a patient partners with their oncologist to integrate personal preferences and values into treatment decisions. A key component of SDM is the elicitation of patient preferences and values, yet little is known about how and when these are elicited, communicated, priori...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.32961

    authors: Williams CP,Miller-Sonet E,Nipp RD,Kamal AH,Love S,Rocque GB

    更新日期:2020-08-01 00:00:00

  • Potentially avoidable hospitalizations after chemotherapy: Differences across medicare and the Veterans Health Administration.

    abstract:BACKGROUND:The Centers for Medicare and Medicaid Services (CMS) has released quality measures regarding potentially avoidable hospitalizations visits in the 30 days after receipt of outpatient chemotherapy. This study evaluated the proportions of patients treated by Medicare-reimbursed clinicians and Veterans Health Ad...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.32896

    authors: Gidwani-Marszowski R,Faricy-Anderson K,Asch SM,Illarmo S,Ananth L,Patel MI

    更新日期:2020-07-15 00:00:00

  • 11p15.5 epimutations in children with Wilms tumor and hepatoblastoma detected in peripheral blood.

    abstract:BACKGROUND:Constitutional or somatic mosaic epimutations are increasingly recognized as a mechanism of gene dysregulation resulting in cancer susceptibility. Beckwith-Wiedemann syndrome is the cancer predisposition syndrome most commonly associated with epimutation and is extremely variable in its phenotypic presentati...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.32907

    authors: Fiala EM,Ortiz MV,Kennedy JA,Glodzik D,Fleischut MH,Duffy KA,Hathaway ER,Heaton T,Gerstle JT,Steinherz P,Shukla N,McNeer N,Tkachuk K,Bouvier N,Cadoo K,Carlo MI,Latham A,Dubard Gault M,Joseph V,Kemel Y,Kentsis A,

    更新日期:2020-07-01 00:00:00

  • Familial risk of breast cancer by dynamic, accumulative, and static definitions of family history.

    abstract:BACKGROUND:Familial breast cancer risk studies usually overlook the dynamic nature of family history. METHODS:The authors assessed the effect of incorporating the timing of cancer diagnosis events into the assessment of familial risks of breast cancer in first-degree and second-degree relatives in a nationwide cohort ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.32815

    authors: Mukama T,Kharazmi E,Sundquist K,Sundquist J,Brenner H,Fallah M

    更新日期:2020-06-15 00:00:00

  • The Chicago Consensus on peritoneal surface malignancies: Management of colorectal metastases.

    abstract::The Chicago Consensus Working Group provides multidisciplinary recommendations for the management of colorectal cancer specifically as it relates to the management of peritoneal surface malignancy. These guidelines are developed with input from leading experts, including surgical oncologists, medical oncologists, path...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.32874

    authors: Chicago Consensus Working Group.

    更新日期:2020-06-01 00:00:00

  • Health-related quality of life among breast cancer survivors and noncancer controls over 10 years: Pink SWAN.

    abstract:BACKGROUND:The goal of this study was to compare health-related quality of life (HRQL) from diagnosis to 10 years postdiagnosis among breast cancer survivors (BCS) and women without cancer over the same period and to identify BCS subgroups exhibiting different HRQL trajectories. METHODS:Our analysis included 141 BCS a...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.32757

    authors: Avis NE,Levine B,Goyal N,Crawford SL,Hess R,Colvin A,Bromberger JT,Greendale GA

    更新日期:2020-05-15 00:00:00

  • Breast cancer patient advocacy: A qualitative study of the challenges and opportunities for civil society organizations in low-income and middle-income countries.

    abstract:BACKGROUND:Breast cancer advocacy movements, driven by advocate-led civil society organizations (CSOs), have proven to be a powerful force for the advancement of cancer control in high-income countries (HICs). However, although patient advocacy movements are growing in low-income and middle-income countries (LMICs) in ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.32852

    authors: Dvaladze A,Kizub DA,Cabanes A,Nakigudde G,Aguilar B,Zujewski JA,Duggan C,Anderson BO,Pritam Singh RK,Gralow JR

    更新日期:2020-05-15 00:00:00

  • Significance of minimal residual disease monitoring by real-time quantitative polymerase chain reaction in core binding factor acute myeloid leukemia for transplantation outcomes.

    abstract:BACKGROUND:Despite the well-defined role of minimal residual disease (MRD) monitoring by real-time quantitative polymerase chain reaction (RT-PCR) for RUNX1/RUNX1T1 and CBFB-MYH11 transcripts in core binding factor (CBF) acute myeloid leukemia (AML) after intensive chemotherapy, there has been a paucity of data assessi...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.32769

    authors: Yalniz FF,Patel KP,Bashir Q,Marin D,Ahmed S,Alousi AM,Chen J,Ciurea SO,Rezvani K,Popat UR,Shpall EJ,Champlin RE,Oran B

    更新日期:2020-05-15 00:00:00

  • Association between nonadherence to cardiovascular risk factor medications after breast cancer diagnosis and incidence of cardiac events.

    abstract:BACKGROUND:Cardiovascular disease (CVD) is the leading cause of death among patients with early-stage breast cancer (BC), but adherence to cardiovascular disease risk factor (CVD-RF) medications is reported to be poor in BC survivors. The objective of the current study was to determine the association between nonadhere...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.32690

    authors: Hershman DL,Accordino MK,Shen S,Buono D,Crew KD,Kalinsky K,Trivedi MS,Hur C,Hu J,Unger JM,Wright JD

    更新日期:2020-04-01 00:00:00

  • Screening young adult cancer survivors with the PROMIS Depression Short Form (PROMIS-D-SF): Comparison with a structured clinical diagnostic interview.

    abstract:BACKGROUND:The current study was conducted to evaluate the Patient-Reported Outcomes Measurement Information System Depression Short Form (PROMIS-D-SF) as a screening measure for young adult cancer survivors (YACS) compared with a structured diagnostic interview. METHODS:A total of 249 YACS (aged 18-40 years) complete...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.32689

    authors: Recklitis CJ,Blackmon JE,Chang G

    更新日期:2020-04-01 00:00:00

  • 2b or not 2b? Shoulder function after level 2b neck dissection: A double-blind randomized controlled clinical trial.

    abstract:BACKGROUND:Selective neck dissection (SND) is a mainstay of head and neck cancer treatment. A common sequela is shoulder syndrome from spinal accessory nerve (SAN) trauma. Extensive dissection in neck levels 2 and 5 leads to SAN dysfunction. However, it is not known whether limited level 2 dissection reduces SAN injury...

    journal_title:Cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/cncr.32681

    authors: Dziegielewski PT,McNeely ML,Ashworth N,O'Connell DA,Barber B,Courneya KS,Debenham BJ,Seikaly H

    更新日期:2020-04-01 00:00:00

  • Long-term results of a phase 2 trial of nilotinib 400 mg twice daily in newly diagnosed patients with chronic-phase chronic myeloid leukemia.

    abstract:BACKGROUND:Nilotinib is a potent, second-generation inhibitor of BCR-ABL1 tyrosine kinase and has been approved as frontline and salvage therapy for patients with chronic-phase chronic myeloid leukemia (CP-CML). METHODS:In this single-institution, phase 2 study, 122 patients with newly diagnosed CP-CML received niloti...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.32623

    authors: Masarova L,Cortes JE,Patel KP,O'Brien S,Nogueras-Gonzalez GM,Konopleva M,Verstovsek S,Garcia-Manero G,Ferrajoli A,Kadia TM,Ravandi-Kashani F,Borthakur G,DellaSala S,Estrov Z,Jabbour EJ,Kantarjian HM

    更新日期:2020-04-01 00:00:00

3242 条记录 1/82 页 « 12345678...8182 »